CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-25 | Nguyen Tran See Remarks | Grant or award · Stock Option (Right to Buy) | +84,000 | 84,000 | ||
| 2021-02-25 | Smith Brandon S. Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +56,000 | 56,000 | ||
| 2021-02-25 | Kinney Gene G. President and CEO | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2021-02-25 | Kinney Gene G. President and CEO | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2021-02-25 | Tripuraneni Radhika Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +56,000 | 56,000 | ||
| 2021-02-25 | Malecek Michael J See Remarks | Grant or award · Stock Option (Right to Buy) | +56,000 | 56,000 | ||
| 2021-02-25 | Karp Carol D. Chief Regulatory Officer | Grant or award · Stock Option (Right to Buy) | +56,000 | 56,000 | ||
| 2021-02-25 | Walker Karin L Chief Accounting Officer | Grant or award · Employee Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2021-02-25 | Zago Wagner M. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +56,000 | 56,000 | ||
| 2021-02-24 | EcoR1 Capital, LLC 10% owner | Purchase | +10,800 | $22.02 | $238K | 10,159,280 |
| 2021-02-23 | EcoR1 Capital, LLC 10% owner | Purchase | +44,400 | $21.05 | $935K | 10,148,480 |
| 2021-02-18 | EcoR1 Capital, LLC 10% owner | Purchase | +44,100 | $23.65 | $1.0M | 10,104,080 |
| 2021-02-18 | EcoR1 Capital, LLC 10% owner | Purchase | +44,100 | $3.68 | $162K | 10,104,080 |
| 2021-02-18 | Zago Wagner M. Chief Scientific Officer | Option exercise | +7,540 | $6.41 | $48K | 7,540 |
| 2021-02-18 | Zago Wagner M. Chief Scientific Officer | Sale | −7,540 | $25.50 | $192K | 0 |
| 2021-02-18 | Zago Wagner M. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −7,540 | 0 | ||
| 2021-02-17 | EcoR1 Capital, LLC 10% owner | Purchase · Call Option | +2,500 | $3.68 | $9K | 2,500 |
| 2021-02-17 | EcoR1 Capital, LLC 10% owner | Purchase | +198,840 | $23.46 | $4.7M | 10,059,980 |
| 2021-02-17 | EcoR1 Capital, LLC 10% owner | Purchase · Call Option | +2,500 | $3.68 | $9K | 2,500 |
| 2021-02-16 | EcoR1 Capital, LLC 10% owner | Purchase | +89,200 | $22.78 | $2.0M | 9,861,140 |
Page 35 of 41 · 819 trades